Indian Pharma Market Plunges Further In October; Is Multiple Branding Eroding Sales?
This article was originally published in PharmAsia News
Executive Summary
Continuing slowdown in the Indian pharmaceutical market is turning into a big worry for an industry already reeling under the effects of a new pricing policy and conflicts with traders over margins. Analysts suggest multiple branding may be the root cause of declining sales.